Pharma Firms Accused of Falsifying Alzheimer's Study Data

Business Insider Australia reported that Japan’s health ministry is probing claims that falsified data was used in an Alzheimer’s disease study involving major pharmaceutical firms, a day after filing an unrelated criminal complaint against Swiss drugs giant Novartis (NYSE:NVS).
As quoted in the market news:

Health officials said they were questioning researchers after being told false data was used in clinical testing for the $US28 million government-backed Alzheimer’s study, aimed at improving diagnosis of the disease.
The research involved 11 drugs firms, including Pfizer and Bristol-Myers Squibb and Japanese giants Takeda Pharmaceutical and Astellas Pharma, medical imaging companies and nearly 40 hospitals and medical organisations. The public and privately-financed study, dubbed J-ADNI, began in 2007.

Read the full post on Business Insider Australia